AGP Picks
View all

Tech Times of New York
Provided by AGP

Tech Times of New York: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tech Times of New York.

July 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

August 2026

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30
31

September 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6
7 8 9 10 11 12 13
14 15 16 17 18 19 20
21 22 23 24 25 26 27
28 29 30

Press releases published on July 13, 2026

AICFDPRO Releases Comprehensive Analysis on Enterprise AI Development Methodologies
Jul. 13, 2026

AICFDPRO Releases Comprehensive Analysis on Enterprise AI Development Methodologies

Indeterminate GlobeNewswire
Symphony Solutions Raises ₴1 Million for Ukraine’s Children’s Mobile Hospice Through Distance for a Difference
Jul. 13, 2026

Symphony Solutions Raises ₴1 Million for Ukraine’s Children’s Mobile Hospice Through Distance for a Difference

Indeterminate GlobeNewswire
New Phase 1 Data Show VNA-318 Mechanism of Action Translates to Humans, Supporting Potential to Address Medical Needs of People with Neurodegenerative Diseases
Jul. 13, 2026

New Phase 1 Data Show VNA-318 Mechanism of Action Translates to Humans, Supporting Potential to Address Medical Needs of People with Neurodegenerative Diseases

Indeterminate GlobeNewswire
Webuy Launches AI Agent-Assisted Smart Travel Card to Enhance Connected Travel Experience
Jul. 13, 2026

Webuy Launches AI Agent-Assisted Smart Travel Card to Enhance Connected Travel Experience

Indeterminate GlobeNewswire
Omnix Medical Launches New Horizon Europe PEPTAMR Infectious Disease Consortium
Jul. 13, 2026

Omnix Medical Launches New Horizon Europe PEPTAMR Infectious Disease Consortium

Indeterminate GlobeNewswire
Alamar Biosciences Partners with Leading Research Universities to Launch National Initiative Advancing Blood-Based Biomarkers for Neurodegenerative Diseases
Jul. 13, 2026

Alamar Biosciences Partners with Leading Research Universities to Launch National Initiative Advancing Blood-Based Biomarkers for Neurodegenerative Diseases

Indeterminate GlobeNewswire
Alamar Biosciences Partners with Leading Research Universities to Launch National Initiative Advancing Blood-Based Biomarkers for Neurodegenerative Diseases
Jul. 13, 2026

Alamar Biosciences Partners with Leading Research Universities to Launch National Initiative Advancing Blood-Based Biomarkers for Neurodegenerative Diseases

Indeterminate GlobeNewswire
SCENESSE® approved for EPP in Canada
Jul. 13, 2026

SCENESSE® approved for EPP in Canada

Indeterminate GlobeNewswire
Santhera erweitert Vereinbarung mit Biomedica zur Ausweitung des Vertriebs von AGAMREE® (Vamorolon) in Zentralasien und im Kaukasus
Jul. 13, 2026

Santhera erweitert Vereinbarung mit Biomedica zur Ausweitung des Vertriebs von AGAMREE® (Vamorolon) in Zentralasien und im Kaukasus

Indeterminate GlobeNewswire
Santhera Expands Biomedica Agreement to Extend AGAMREE® (Vamorolone) Distribution Across Central Asia and the Caucasus
Jul. 13, 2026

Santhera Expands Biomedica Agreement to Extend AGAMREE® (Vamorolone) Distribution Across Central Asia and the Caucasus

Indeterminate GlobeNewswire
Palomino Laboratories Common Stock Commences Trading on the OTCQB VENTURE MARKET
Jul. 13, 2026

Palomino Laboratories Common Stock Commences Trading on the OTCQB VENTURE MARKET

Indeterminate GlobeNewswire
Alarum Investor News: If You Have Suffered Losses in Alarum Technologies Ltd. (NASDAQ: ALAR), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
Jul. 13, 2026

Alarum Investor News: If You Have Suffered Losses in Alarum Technologies Ltd. (NASDAQ: ALAR), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

Indeterminate GlobeNewswire
ROSEN, RECOGNIZED INVESTOR RIGHTS COUNSEL, Encourages Verra Mobility Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - VRRM
Jul. 13, 2026

ROSEN, RECOGNIZED INVESTOR RIGHTS COUNSEL, Encourages Verra Mobility Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - VRRM

Indeterminate GlobeNewswire
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages PicS N.V. Investors to Secure Counsel Before Important Deadline in Securities Class Action – PICS
Jul. 13, 2026

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages PicS N.V. Investors to Secure Counsel Before Important Deadline in Securities Class Action – PICS

Indeterminate GlobeNewswire
New Crypto: AlphaPepe Presale Solidifies AI DEX Rollout As XRP Price Prediction Eyes Next Shiba Inu Move
Jul. 13, 2026

New Crypto: AlphaPepe Presale Solidifies AI DEX Rollout As XRP Price Prediction Eyes Next Shiba Inu Move

Indeterminate GlobeNewswire
First Hawaiian to Report Second Quarter 2026 Financial Results on July 24, 2026
Jul. 13, 2026

First Hawaiian to Report Second Quarter 2026 Financial Results on July 24, 2026

Indeterminate GlobeNewswire
SPORTRADAR DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, Encourages Sportradar Group AG Investors with Losses in Excess of $100K to Secure Counsel Before Important July 17 Deadline in Securities Class Action - SRAD
Jul. 13, 2026

SPORTRADAR DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, Encourages Sportradar Group AG Investors with Losses in Excess of $100K to Secure Counsel Before Important July 17 Deadline in Securities Class Action - SRAD

Indeterminate GlobeNewswire
ROSEN, LEADING INVESTOR COUNSEL, Encourages Hub Group, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - HUBG
Jul. 13, 2026

ROSEN, LEADING INVESTOR COUNSEL, Encourages Hub Group, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - HUBG

Indeterminate GlobeNewswire

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Tech Times of New York

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.